Survey of Ophthalmology
Volume 55, Issue 4 , Pages 378-385, July 2010

Drug-induced Optic Neuropathy—TB or Not TB

  • Monika Pradhan, MS, MRCOphth

      Affiliations

    • Department of Ophthalmology, National Eye Centre, University of Auckland, New Zealand
    • Department of Ophthalmology, Greenlane Clinical Centre, Auckland District Health Board, New Zealand
  • ,
  • Dianne Sharp, FRANZCO

      Affiliations

    • Department of Ophthalmology, National Eye Centre, University of Auckland, New Zealand
  • ,
  • Stephen Best, FRANZCO

      Affiliations

    • Department of Ophthalmology, National Eye Centre, University of Auckland, New Zealand
  • ,
  • Andrea Vincent, FRANZCO

      Affiliations

    • Department of Ophthalmology, National Eye Centre, University of Auckland, New Zealand
    • Department of Ophthalmology, Greenlane Clinical Centre, Auckland District Health Board, New Zealand
    • Corresponding Author InformationReprint address: Dr Andrea Vincent, Department of Ophthalmology, University of Auckland, Private Bag 92019, Auckland, New Zealand.
  • ,
  • Michael Vaphiades, DO

      Affiliations

    • Department of Ophthalmology, University of Alabama, Birmingham, Alabama, USA

published online 18 January 2010.

Peter Savino and Helen Danesh-Meyer, Editors

Abstract 

Autosomal dominant optic atrophy is an inherited optic neuropathy manifesting with variable penetrance and expressivity. Other genetic and environmental factors are postulated to contribute to more marked visual loss in some affected individuals. Optic neuropathy is also a known adverse effect of ethambutol therapy for tuberculosis. This case report demonstrates an atypical presentation of ethambutol toxicity, with progressive profound loss of vision despite drug cessation. A subsequent diagnosis of autosomal dominant optic atrophy was made when the proband's sons presented with mild visual disturbances and color vision defects, confirmed with electrophysiology and OPA1 gene mutational analysis. This case emphasizes the importance of avoiding potentially neurotoxic therapy in predisposed individuals and the influence of environmental factors in patients with inherited optic neuropathies.

Key words: autosomal dominant optic atrophy, ethambutol, OPA1 gene

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(09)00269-0

doi:10.1016/j.survophthal.2009.10.005

Survey of Ophthalmology
Volume 55, Issue 4 , Pages 378-385, July 2010